Summary
Hypersection of mucus is the main feature of chronic bronchitis and is associated with an increased susceptibility to bronchial infections. Although airway inflammation is present in patients with chronic bronchitis and is recognised as a contributing factor in the development of bronchial hyper-reactivity and obstruction, the role of anti-inflammatory drugs in the treatment of chronic bronchitis has not been established. Nimesulide is a nonsteroidal anti-inflammatory drug that can modulate the function of neutrophils and block the effects of several inflammatory mediators. We found that a 3-week treatment course of nimesulide in patients with chronic mucus hypersecretion decreased sputum viscosity, thus significantly improving symptoms. The effect of nimesulide on the rheological properties of mucus was slower and weaker than that of classic mucolytics and was more likely to be related to a reduction in bronchovascular permeability. The clinical usefulness of nimesulide in chronic bronchitis deserves further investigation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams GK, Lichtenstein LM. Indomethacin enhances response of human bronchus to antigen. American Review of Respiratory Disease 131: 8–10, 1985
Adcock JJ, Garland LG, Moncada S, Salmon JA. Enhancement of anaphylactic mediator release from guinea-pig perfused lungs. Prostaglandins 16: 63–77, 1978
Annesi I, Kauffmann F. Is respiratory mucus hypersecretion really an innocent disorder? American Review of Respiratory Disease 134: 688–693, 1986
Boschetto P, Rogers DF, Fabbri LM, Barnes PJ. Corticosteroid inhibition of airway microvascular leakage. American Review of Respiratory Disease 143: 605–609, 1991
Capsoni F, Venegoni E, Minonzio F, Ongari AM, Maresca V, et al. Inhibition of neutrophils oxidative mechanism by nimesulide. Agents and Actions 21: 121–129, 1987
Carratù L, Marangio E, Cuomo A, Pesci A, Sofia M, et al. Physico-chemical and Theological research on mucolytic activity of serratio-peptidase in chronic bronco-pneumopathies. Current Therapeutic Research 28: 937–951, 1980
Carratù L, Marangio E, Cuomo A, Pesci A, Sofia M, et al. Physico-chemical and rheological research on mucolytic activity of thiopronine in chronic bronco-pneumopathies. Current Therapeutic Research 32: 529–543, 1982
Clarke SW. Chronic bronchitis in the 1990s: up-to-date treatment. Respiration 58 (Suppl. 1): 43–46, 1991
Fick RB, Metzger WJ, Richarson HB, Zavala DC, Moseley PL, et al. Increased bronchovascular permeability after allergen exposure in sensitive asthmatics. Journal of Applied Physiology 63: 1147–1155, 1987
Finiguerra M, Conti P, Gallone F, Ferraris F. Un nuovo antiin-fiammatorio non steroideo, nimesulide, nelle forme infiammatorie di interesse pneumologico. Clinica Terapeutica 3: 199–206, 1986
Honda I, Shimura S, Sasaki T, Takishima T, Nakamura M. Airway mucosal permeability in chronic bronchitis and bronchial asthmatics with hypersecretion. American Review of Respiratory Disease 37: 866–871, 1988
Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. Lancet 1: 775–779, 1965
Mullen B, Wright J, Wiggs B, Paré P, Hogg J. Structure of central airways in current smokers and ex smokers with and without, mucus hypersecretion: relationship to lung function. Thorax 42: 843–848, 1987
Nadel JA. Role of mast cell and neutrophil proteases in airway secretions. American Review of Respiratory Disease 144: S48–S51, 1991
Olivieri D, Marsico SA, Del Donno M. Improvement of muco-ciliary transport in smokers by mucolytics. European Journal of Respiratory Disease 66 (Suppl. 139): 142–145, 1985
Pavia D. Lung mucociliary clearance. In Clarke SW, Pavia D (Eds) Aerosols and the lung: clinical and experimental aspects, pp. 127–155, Butterworths, London, 1984
Pavia D, Agnew JE, Sutton PP, Lopez-Vidriero MT, Currie DC, et al. Impaired mucus clearance in patients with chronic bronchial sepsis, sinusitis and dextrocardia. Respiration 53: 187–196, 1988
Feto R, Speizer F, Cochrane A, Moore F, Flechter C, et al. The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. American Review of Respiratory Disease 128: 491–500, 1983
Sofia M, Molino A, Mormile M, Stanziola A, De Simone F, et al. Modificazioni dei parametri clinici e dellie proprietà reologiche dell’espettorato durante il trattamento con nimesulide in pazienti affetti da bronchite cronica. Studio controllato verso, placebo. Giornale Italiano delle Malattie del Torace 45: 24–28, 1991a
Sofia M, Stanziola A, Mormile M, De Simone F, Carratù L. Difference between changes of bronchial mucosa permeability during endobronchial or inhaled allergenic challenge. European Respiratory Journal 4 (Suppl. 14): 595S, 1991b
Thurlbeck W. Aspects of chronic airflow obstruction. Chest 72: 341–349, 1977
Wanner A. Clinical aspects of mucociliary transport. American Review of Respiratory Disease 116: 73–125, 1977
Witheside ME, Lauredo I, Chapman GA, Ratzan KR, Abraham WM, et al. Effect of atropine on tracheal mucociliary clearance and bacterial counts. Bulletin Europeèn de Physiopathologie Respiratoire 20: 347–351, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sofia, M., Molino, A., Mormile, M. et al. Nimesulide in the Treatment of Chronic Bronchitis. Drugs 46 (Suppl 1), 111–114 (1993). https://doi.org/10.2165/00003495-199300461-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199300461-00023